image
Healthcare - Biotechnology - NASDAQ - US
$ 7.275
4.39 %
$ 737 M
Market Cap
-7.0
P/E
Price Target Average
386.99%
Revenue Forecast Estimate
50.71%
EBIT Estimate
40.25%
Net Income Estimate
41.27%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Day One Biopharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for DAWN of $35.4 , with forecasts ranging from a low of $24 to a high of $45 .
DAWN Lowest Price Target Wall Street Target
24 USD 229.90%
DAWN Average Price Target Wall Street Target
35.4 USD 386.99%
DAWN Highest Price Target Wall Street Target
45 USD 518.56%
Price
Max Price Target
Min Price Target
Average Price Target
4545404035353030252520201515101055Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart DAWN

image
$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart DAWN

image
$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart DAWN

image
$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)20232023202420242025202520262026202720272028202820292029